Read more
Read less
A conference co-presented by the IBA Intellectual Property and Entertainment Law Committee, IBA Technology Law Committee and the IBA Healthcare and Life Sciences Law Committee
Topics will include
- Trends in gene therapy and personalized medicine
- Navigating the Intersection of Patent Strategies and Antitrust Regulations in the Pharmaceutical Industry: Lessons from the Teva Copaxone Case
- Continued Acceleration in the Use and regulation of Artificial Intelligence, including Gen AI
- Navigating the Evolving Global Health Data Privacy Laws
- Trends in Life Sciences M&A, Investment, and Strategic Collaborations
- Regulatory Trends in Drug Pricing and Market Access: Strategies for Compliance and Advocacy
- Strategies for managing Scarcity & Shortages in the Supply of Drugs, Medical Devices, and other essential Goods
- 3D Printing of Medical Devices
- Counterfeit Pharmaceuticals: Innovative Strategies for Combatting Global Health Threats
- Decoding Anticorruption Risks in the Life Sciences Sector
- Telemedicine and advanced practice of medicine
- Trends in cross-border patent litigation strategies amid evolving frameworks
Headline social event sponsor
Speaker opportunities
If you would like to be considered as a potential speaker at this specialist conference then please contact the relevant Chair/Co-Chairs in the IBA Intellectual Property and Entertainment Law Committee, Chair/Co-Chairs in the IBA Technology Law Committee or Chair/Co-Chairs in the IBA Healthcare and Life Sciences Law Committee with your request; please send your bio together with information on your qualification and expertise on the topic.